lomecel-b
Cell therapyexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 30, 2017 (NCT03169231)
Timeline
Indications
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04925024 | Phase 2 | Jun 25, 2021 | Longeveron LLC, National Heart, Lung, and Blood Institute (NHLBI), Northwestern University, University of Texas at Houston |
| NCT04629105 | Phase 1 | Jul 24, 2020 | Longeveron LLC |
| NCT03169231 | Phase 2 | Jul 30, 2017 | Longeveron LLC, Stanford University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Longeveron LLC | For profit | 3 | 2 | 2 | 2017 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 0 | 1 | 2021 |
| Northwestern University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Stanford University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of Texas at Houston | Academic/Hospital | 1 | 0 | 1 | 2021 |
5 organizations
Page 1 / 1